2016 International Congress Archives - Page 6 of 207

P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson’s disease

M. Kohsaka, T. Oeda, A. Umemura, S. Tomita, K. Park, K. Yamamoto, H. Sugiyama, H. Sawada (Kyoto, Japan)
Paediatric and adult-onset parkinsonism in Chediak-Higashi disease: A new family

M. Carecchio, E. Salsano, A. Legati, C. Lamperti, E. Corsini, B. Garavaglia, D. Pareyson, D. Ghezzi (Milan, Italy)
Pain correlates with sleep disturbances in Parkinson’s disease

Y. Fu, C. Mao, L. Ma, M. Ding, Y. Wang, C. Liu (Suzhou, People's Republic of China)
Pain-motor integration in the primary motor cortex in Parkinson’s disease

A. Suppa, C. Leone, F. Di Stasio, A. Biasiotta, L. Marsili, S. La Cesa, A. Di Santo, G. Fabbrini, G. Cruccu, A. Berardelli (Rome, Italy)
Painful legs and moving toes (PLMT) treatment with topic capsaicin: A case report

F.S. Tensini, T.S. Tensini, H.A.G. Teive (Curiitba, Brazil)
Pallidal DBS and pallidotomy alter cortical synchronization in Parkinson’s disease

S. Miocinovic, C. De Hemptinne, A. Miller, J.L. Ostrem, P.A. Starr (San Francisco, CA, USA)
Pallidal deep brain stimulation improves dystonia in Woodhouse-Sakati syndrome

J.Y. Chen, J.L. Ostrem, B. Lee, P. Starr, A. Viehoever (San Francisco, CA, USA)
Pallidal low frequency activity correlates with dystonic symptoms in patients with cervical dystonia

W.J. Neumann, J. Huebl, C. Brücke, C. Slentz, G.H. Schneider, A.A. Kühn (Berlin, Germany)
Pallidal versus subthalamic stimulation for PD: Beyond the motor effects

M.G. dos Santos Ghilardi, R.G. Cury, R.C.R. Martinez, M.J. Teixeira, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)
Pan American multiple system atrophy (PANMSA) consortium database

M. Cesarini, A. Sanguinetti, J. Etcheverry, E. Mosto, I. Litvan, E.M. Gatto (Buenos Aires, Argentina)
Pantotenate kinase associated neurodegeneration (PKAN): Proposal for a clinical rating scale

A. Darling, C. Garrido, S. Aguilera, M. Tomas-Vila, I. Gaston, M. Madruga, L. González-Gutiérrez, J. Ramos-Lizana, M. Pujol, K. Tustin, J.P. Lin, L. Martorell, C. Tello, V. Lupo, C. Espinos, L. Stefanis, L. Sanz, F. Gutiérrez, P.J. Garcia, L. Vela, T. Temudo, R. Pons, M.J. Martí, B. Pérez-Dueñas (Barcelona, Spain)
Parasacral effects of electrical stimulation on lower urinary tract symptoms and constipation in patients with Parkinson’s disease: Preliminary data

I.V. Brandi, L.F. Silva, A.M. Lanzarini, A.F.A. Musengante (Salvador, Brazil)
Parietal hand pseudodystonia: Significant functional gains with ultrasound-guided botulinum toxin treatments

P. Pita Lobo, C. Costa (Amadora, Portugal)
PARK-OMM – An osteopathic manipulative medicine protocol to improve motor function and balance in Parkinson’s disease

S. Yao, K. de Vries, J. DiFrancisco-Donoghue, J. Mancini, M.K. Jung, G. Cheriyan, S. Curtis, A. Leder (Old Westbury, NY, USA)
Parkinson patient reported outcomes of voice and communication pre, post and 6 months following LSVT LOUD® and LSVT ARTIC

A.E. Halpern, L.O. Ramig, K. Freeman, J.L. Spielman (Denver, CO, USA)
Parkinson’s disease (PD) quality improvement measures (QIM) and outcomes study

J. Martello, L. Shulman, M. Armstrong, S. Reich (Baltimore, MD, USA)
Parkinson’s disease and the frequent reasons for emergency admission in Metropolitan Medical Center; a 2 year retrospective study

C.L. Go, K.A. Wong (Manila, Philippines)
Parkinson’s disease associated psychosis: Prevalence and risk factors

A. Dutt, H. Kumar, M. Mukherjee, M.U. Kulsum, C. Sengupta (Kolkata, India)
Parkinson’s disease characteristics in patients with Gaucher’s disease

A. Thaler, A. Mirelman, E. Shimoni, M. Victor, O. Assais, M. Grumberg, T. Gurevich, T. Shiner, M. Gana Weisz, A. Orr Urtreger, N. Giladi (Tel-Aviv, Israel)
Parkinson’s disease is characterised by differences in lower limb joint kinetics during stair ascent and descent

Z.J. Conway, T.D. Blackmore, P.A. Silburn, M.H. Cole (Brisbane, Australia)
Parkinson’s disease motor subtypes show similar deficits in inhibitory control

C.M. Tolleson, M. Turchan, N. van Wouwe, S.A. Wylie (Nashville, TN, USA)
Parkinson’s disease onset on non-dominant side predicts greater motor disability

T.A. Finseth, S. Sillau, B. Berman (Aurora, CO, USA)
Parkinson’s disease patients with onset in right side have a worse cognitive prognosis

T. Poliakova, I. Zerr, O. Levin (Belgorod, Russia)
Parkinson’s disease prodromal dysautonomia versus pure autonomic failure and MSA

M. Rosso, A. Merola, A.J. Espay, S. Maule, M. Zibetti, A. Romagnolo, L. Lopiano (Torino, Italy)
Parkinson’s disease-associated Miro1 mutants cause mitochondrial dysfunction

D. Grossmann, D. Scheibner, J. Fitzgerald, W. Mätzler, L. Burbulla, R. Krüger (Belvaux, Luxembourg)
Parkinson’s disease-linked mutation in DNAJC13 causes specific trafficking defect in endosomal pathway

S. Yoshida, T. Hasegawa, R. Oshima, J. Kobayashi, N. Sugeno, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)
Parkinson’s in an aging population: Implications from a nation-wide prevalence and incidence study in New Zealand

D.J. Myall, T.L. Pitcher, M.R. MacAskill, J.F. Pearson, C.J. Lacey, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)
Parkinson’s syndrome as possible manifestation of lamina quadrigemina tumor or inflammation

N.M. Pavlyshyna, I.V. Khubetova (Odessa, Ukraine)
Parkinsonian symptoms in patients with cervical dystonia treated with bilateral pallidal deep brain stimulation: A controlled study

D. Georgiev, P. Mahlknecht, F. Brugger, S. Vinke, A. Zacharia, T. Grover, L. Zrinzo, M. Hariz, K.P. Bhatia, M. Jahanshahi, E. Tripoliti, G.M. Hariz, T. Foltynie, P. Limousin (Ljubljana, Slovenia)
Parkinsonian syndrome prevalence in the world

F. Gulyamova (Tashkent, Uzbekistan)
Parkinsonism and movement disorders in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

I. Amorín, A. Lescano, A. Panuncio, V. Raggio, R. Buzó (Montevideo, Uruguay)
Parkinsonism due to hypermanganism in the background of cirrhosis and recovery by CaNaEDTA

B. Elibol, H. Onder, G.Y. Cakmakli, E.S. Topcuoglu (Ankara, Turkey)
Parkinsonism in patients with CADASIL

S.K. Song, J.H. Kang (Jeju-si, Korea)
Parkinsonism risk factors in Salt Lake City, Utah

D. Shprecher, K. Gannon, M. Halverson, R. Savica (Sun City, AZ, USA)
Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency

M. Quadri, M. Skorvanek, S. Olgiati, M. Minneboo, J. Graafland, G.J. Breedveld, R. Bonte, Z. Ozgur, K. Schoonderwoerd, F.W. Verheijen, W.F.J. van Ijcken, H. Fen Chien, E. Reis Barbosa, H.C. Chang, S.C. Lai, T.H. Yeh, C.S. Lu, Y.H. Wu-Chou, A.J.A. Kievit, V. Han, Z. Gdovinova, R. Jech, R.M.W. Hofstra, G.J.G. Ruijter, W. Mandemakers, V. Bonifati (Rotterdam, Netherlands)
Participant feedback in the PREDICT-PD study

C.W. Osborne, J. Bestwick, G. Giovannoni, A.J. Lees, A. Schrag, A. Noyce (London, United Kingdom)
Participation in cognitively-stimulating activities and computer use are associated with better cognitive performance in Parkinson’s disease independent from nigrostriatal dopaminergic and cortical cholinergic degenerations

J.L.B. Bohnen, M.L.T.M. Muller, J.D.J. Haugen, N.I. Bohnen (Ann Arbor, MI, USA)
Pathological findings from two Parkinson’s disease patients after intraputaminal GDNF infusion

T.R. Yamasaki, V.D. Smith, Y. Ai, D.M. Gash, P.T. Nelson, G.A. Gerhardt, J.T. Slevin (Lexington, KY, USA)
Pathophysiological mechanisms of bone mass loss for osteoporosis prevalence in Parkinson’s disease

L.A. Leandro, H.A.G. Teive (Curitiba, Brazil)
Patient case reports supporting a long-term effect of sub-anesthetic ketamine infusion in reducing L-DOPA-induced dyskinesias

S.J. Sherman, T. Falk (Tucson, AZ, USA)
Patient experiences following Parkinson’s disease treatment with inhaled levodopa: Results from a Phase 2b study

P. LeWitt, A. Niyazov, A. Sedkov, H. Murck, A. Guo (West Bloomfield, MI, USA)
Patient reported outcomes in Parkinson’s disease (PRO-PD) rating scale validation

L.K. Mischley (Kenmore, WA, USA)
Patient satisfaction with flexible botulinum toxin injection intervals – Preliminary results of a telephone survey

C. Linder, S. Macher, E. Auff, T. Sycha (Vienna, Austria)
Patient-centered educational intervention using hand-held electronic devices

N. Hellmers, A. Hanineva, J.C. Stribling, J. Carter, C. Henchliffe (New York, NY, USA)
Patient-centered outcomes of DBS in Parkinson’s disease

J. Karl, B. Ouyang, K. Colletta, L. Verhagen (Chicago, IL, USA)
Patients’ employment status and quality of life affect caregivers burden in Parkinson’s disease in Singapore

K.M. Prakash, N.V. Nadkarni, W.K. Lye, E.C. Lim, E.K. Tan (Singapore, Singapore)
PD COMM Pilot: A pilot randomised controlled trial of Lee Silverman voice treatment (LSVT) versus NHS speech and language therapy versus no intervention in Parkinson’s

C.M. Sackley, S. Patel, R. Woolley, N.J. Ives, C.E. Rick, F. Dowling, K. Wheatley, C. Smith, M. Brady, C.E. Clarke (London, United Kingdom)
Perception of the visual vertical is not impaired in patients with idiopathic cervical dystonia

J. De Pauw, R. Mercelis, W. Saeys, S. Truijen, P. Cras, W. De Hertogh (Antwerp, Belgium)
Perception of time in music in Parkinson´s disease – Processing of musical syntax compensates rhythmic deficits

D. Bellinger, E. Altenmüller, J. Volkmann (Wuerzburg, Germany)
PERFORM: Controlled study in fluctuating PD patients examining the effects of motor state on the outcomes resulting from a structured physical therapy (PT) program

J.P. Hubble, B. Fisher, K. Lyons, C. McLean, G. Petzinger, R. Pahwa (Louisville, KY, USA)
Performance in Montreal cognitive assessment and functional independence in Parkinsonian with normal mini-mental state examination

R. Breder, M.A.A. Leite, B.L. Pessoa, C.O. Vilaça (Niterói, Brazil)
Peri-operative dopaminergic replacement protocol with rotigotine in Parkinson’s disease patients

L. Abraira del Fresno, L. Ispierto, A.M. Crespo, T. Canento, D. Vilas, M. Gonzalez, F. Sala, L. Morató, J. Sánchez-Ojanguren, R. Álvarez (Barcelona, Spain)
Peripheral insulin sensitivity and body composition alterations in early stage Machado Joseph disease

J.A. Saute, S.N. Gabriele, C.B. Haas, V.R. Torrez, A.W. Brochier, G.V. Furtado, T.C. Gheno, A.D. Russo, T.L. Monte, A. Schumacher-Schuh, R. D´Avila, K.C. Donius, R.M. Castilhos, D.O. Souza, M.L. Saraiva-Pereira, V.L. Torman, S.A. Camey, C.R.M. Rieder, L.V.C. Portela, L.B. Jardim (Porto Alegre, Brazil)
Peripheral neuropathies in Parkinson’s disease during levodopa-carbidopa intestinal gel treatment: Results from a long-term prospective follow-up study

A. Romagnolo, A. Merola, M. Zibetti, A. Bernardini, D. Cocito, C.A. Artusi, F. Dematteis, S. Angrisano, M.G. Rizzone, L. Lopiano (Turin, Italy)
Persistent drug-induced parkinsonism with normal dopamine transporter imaging

J.W. Lee, J.Y. Hong, J.S. Oh, I. Lee, J.S. Kim, Y.H. Sohn, P.H. Lee (Wonju, Korea)
Persistent hemichorea and caudate atrophy in untreated diabetic striatopathy

B. Krishnaiah, E. Lucassen, M.C. Stahl (Hershey, PA, USA)
Persistent myoclonic dystonia due to SCL2A1 mutation

P.H. McNamara, D. Olszewska, A. McCarthy, J. McKinley, T. McVeigh, T. Lynch (Dublin, Ireland)
Personality and addictive behaviours in prodromal and early Parkinson’s disease

F. BaigBM, M. Lawton, M. Rolinski, C. Ruffmann, J. Klein, K. Nithi, D. Okai, Y. Ben-Shlomo, M.T.M. Hu (Oxford, United Kingdom)
PET examination of the monoamine transporter with 11C-beta-CIT

M. Tábuas-Pereira, F. Oliveira, A. Moreira, M. Sousa, F. Moreira, C. Januário, A. Abrunhosa, M. Castelo-Branco (Coimbra, Portugal)
PET imaging of tau pathology in progressive supranuclear palsy

S. Coakeley, S.S. Cho, P. Rusjan, A. Graff-Guerrero, R. Chen, A.E. Lang, L. Kalia, E. Slow, S. Houle, A.P. Strafella (Toronto, ON, Canada)
Pharmacokinetic profile of ONO-2160/CD (levodopa prodrug/carbidopa) in animal and human

M. Nomoto, M. Nagai, N. Nishikawa, K. Yano, Y. Kagamiishi, M. Akisada, S. Saito, M. Yuba, T. Koyanagi, A. Takeda (Tohon Ehime, Japan)
Pharmacokinetic-pharmacodynamic effects of apomorphine sublingual film (APL-130277) for the rapid management of OFF episodes in patients with Parkinson’s disease

E.J. Pappert, B. Dzyngel, T. Bilbault, A. Agro (Toronto, ON, Canada)
Phenomenology and therapeutic strategies in a series of patients with chorea-acanthocytosis

C. Estevez-Fraga, M. Matarazzo, R. Rigual, P. Garcia Ruiz, L. Vela, M. Kurtis, A. Minguez, R. Luquin, I.J. Posada Rodriguez, M.C. Rodriguez-Oroz, J. García de Yébenes, J.C. Martínez-Castrillo, J.L. López-Sendón (Madrid, Spain)
Phenomenology of dyskinesias induced by subthalamic stimulation in Tourette syndrome

L.M. Romito, D. Calandrella, C. Bagella, G. Messina, F. Ferré, A. Franzini (Milan, Italy)
Phenomenology of idiopathic adult-onset truncal dystonia

D.J. Ehrlich, S.J. Frucht (New York, NY, USA)
Phenotype and genotype variability of CACNA1A in a cohort of ataxia in Taiwan

P.Y. Fong, T.H. Yeh, S.C. Lai, C.S. Lu (Taoyuan City, Taiwan)
Phenotypes in Essential Tremor: Gait analysis and imaging study

E. Boutin, T. Witjas, R. Carron, J. Regis, E. Guedj, J.P. Azulay, M. Vaugoyeau (Marseille, France)
Phenotypic characteristics in GBA-associated Parkinson’s disease (PD): A study in a Greek population

A.M. Simitsi, C. Koros, N. Papagiannakis, R. Antonelou, M. Moraitou, H. Michelakakis, M. Stamelou, L. Stefanis (Athens, Greece)
Phenotypic differences between African American and Caucasian Parkinson’s disease patients

M.O. Bailey, B. Ouyang, G.T. Stebbins, L.M. Shulman, L.L. Barnes, D.A. Hall (Chicago, IL, USA)
Phenotypic insights into ADCY5-associated disease

F.C.F. Chang, A. Westenberger, R.C. Dale, M. Smith, H.S. Pall, B. Perez-Duenas, P. Grattan-Smith, R.A. Ouvrier, N. Mahant, B.C. Hanna, M. Hunter, J.A. Lawson, C. Max, R. Sachdev, E. Meyer, D. Crimmins, D. Pryor, J.G.L. Morris, A. Munchau, D. Grozeva, K.J. Carss, L. Raymond, M.A. Kurian, C. Klein, V.S.C. Fung (Wentworthville, Australia)
Phenotypic spectrum and longitudinal outcome of Parkinson’s disease patients with psychosis

M.S. Nanjunda Swamy, M.M. Abbas, S.T. Govindappa, P. Basu, R. Ramanathan, U.B. Muthane (Bangalore, India)
Phosphorylation by GSK-3β enhances binding of metal ion induced tau oligomers to neutral lipid surfaces

G.S. Nuebling, E. Plesch, T. Högen, S. Lorenzl, F. Kamp, A. Giese (Munich, Germany)
Physical therapy practice variability and outcomes for people with Parkinson’s disease: Data from the National Parkinson Foundation quality improvement initiative (NPF-QII)

M.R. Rafferty, P.N. Schmidt, S.T. Luo, K. Li, F. Cubillos, C. Marras, T. Davis, E.C. Nelson, T. Simuni (Chicago, IL, USA)
Physical therapy, a third wheel in the management of Parkinson’s disease

M.V. Alvarez, M. Rodriguez (San Antonio, TX, USA)
Physical training prevents depressive-like behavior and bdnf decrease in an animal model of Parkinson’s disease

T. Tuon, S.S. Valvasori, J.L. Quevedo, C.T. Souza, R.A. Pinho (Criciúma, Brazil)
Physiological and biomechanical responses of people with Parkinson’s during Zumba Gold®: Effects of dance styles and number of sessions

A. Delextrat, J. Bateman, P. Esser, N. Targen, H. Dawes, M.A. Delextrat (Oxford, United Kingdom)
Physiotherapy can reduce the decline in functioning according to ICF framework in patients in early stage of Parkinson’s disease evolution

E.T.N. Guelfi, E. Okamoto, F.B. Tarallo, J.C. Elmauer, R.R. Fermino, V.F. Giangiardi, P. Yuki, E.P. Piemonte (São Paulo, Brazil)
Pilot study on the long lasting effectivness of an integrated tailored sensory-motor rehabilitation program associated with BoNTA in cervical dystonia

A. Castagna, M. Ramella, A. Crippa, L. Sciumè, G. Giacobbi, C. Corrini, D. Anastasi, A. Montesano (Milano, Italy)
PINK1-dependent clearance of depolarized mitochondria is driven by the UPS and can occur independently of (macro)autophagy

A. Rakovic, J. Ziegler, C.U. Mårtensson, J. Prasuhn, K. Shurkewitsch, P. König, H.L. Paulson, C. Klein (Luebeck, Germany)
Piper longum L. alkaloids inhibit lipopolysaccharide-stimulated microglial activation and protect nigral dopaminergic neurons

H. Yang, C. Duan (Beijing, People's Republic of China)
Piperine potentiates neuroprotective effect of curcumin in MPTP model of Parkinson’s disease in rats: Impact on neurochemical modulation

S. Singh, P. Kumar (Moga, India)
Pisa syndrome in a drug-naive Parkinson’s disease patient

P. Solla, A. Cannas, M.M. Mascia, M. Mancino, D. Picciau, R. Farris, G. Orofino, L. Cugusi, L. Polizzi, F. Marrosu (Monserrato (Cagliari), Italy)
Pisa syndrome in Parkinson’s disease effectively treated with subthalmic deep brain stimulation: Case report

C.A. Artusi, A. Romagnolo, M. Zibetti, M.G. Rizzone, A. Merola, F. Dematteis, M. Lanotte, L. Lopiano (Torino, Italy)
Pisa syndrome in Parkinson’s disease: A mobile orfixed deformity?

E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva, F.K. Shermukhamedova (Taskent, Uzbekistan)
Plasma ceramides and glucosylceramides predict cognitive decline among cognitively normal Parkinson’s disease patients

M.M. Mielke, C.E. Hagen, R. Savica, J.A. Syrjanen, X.M.T. Persson, C. Schulte, R. Dodel, M. Balzer-Geldsetzer, J.B. Schulz, K. Reetz, U. Wullner, A. Spottke, A. Storch, H.U. Wittchen, O. Riedel, E. Kalbe, S. Graber-Sultan, T. Gasser, D. Berg, I. Liepelt-Scarfone (Rochester, MN, USA)
Polyethylenimine (PEI) nanoparticle-mediated delivery of siRNA to silence neuronal gene expression of alpha-synuclein in a mouse model of Parkinson’s disease

C. Helmschrodt, A. Bauer, S. Höbel, S. Schöniger, S.A. Fietz, A. Aigner, A. Richter, F. Richter (Leipzig, Germany)
Post-anoxic myoclonus: Timing matters

K.G. Su, A.L. Hiller (Portland, OR, USA)
Post-traumatic rubral tremor – A rare entity

M. Kaur, S. Kushwaha, S. Khosya (New Delhi, India)
Postural and nonmotor disturbances in Parkinson’s disease

A. Pilipovich, V. Golubev, G. Ptimat (Moscow, Russia)
Potential advantages of high resolution lead designs for deep brain stimulation

J. Wu, M. Astrom, G. Molnar (Minneapolis, MN, USA)
Pre-formed fibrils injection worsen pathology caused by AAV-mediated over expression of α-synuclein

L.S. Breger, P. Thakur, O.W. Wan, B. Mattsson, K. Luk, V.M. Lee, J. Trojanowski, A. Björklund (Lund, Sweden)
Pre-pulse inhibition of blink reflex in cervical dystonia

M. Kiziltan, O. Öztürk, A. Gündüz (Istanbul, Turkey)
Preclinical evaluation of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias: Is it a ‘chemical’ DBS?

T. Falk, M.J. Bartlett, T. Ye, L.B. Lazarus, M.L. Heien, S.L. Cowen, S.J. Sherman (Tucson, AZ, USA)
Predicting incident impulse control disorder behaviour in Parkinson’s disease patients using a clinical-genetic model

J. Kraemmer, K. Smith, D. Weintraub, V. Guillemot, M.A. Nalls, F. Cormier, I. Moszer, A. Brice, A.B. Singleton, J.C. Corvol (Paris, France)
Predicting medication reduction in Parkinson’s disease patients after deep brain stimulation

S.A. Dodwell, C.E. Ashton, D.K. Simon, D. Tarsy, E. Papavassiliou, R. Alterman, L. Shih (Boston, MA, USA)
Predicting poor functional outcome in Parkinson’s disease

A.D. Macleod, C.E. Counsell (Aberdeen, United Kingdom)
Predicting risk of sarcopenia in people with Parkinson’s disease

A.P.C. Loureiro, B. Yamaguchi, I.L.P. Villegas, M.P. Ferreira, V.L. Israel (Curitiba, Brazil)
Predicting therapeutic effects of atomoxetine and citalopram on response inhibition in Parkinson’s disease

J.B. Rowe, C. Rae, C. Nombela, T. Ham, P. Vazquez, I. Coyle-Gilchrist, C.R. Housden, B.J. Sahakian, T.W. Robbins, Z. Yes (Cambridge, United Kingdom)
Predictive performance of EEG theta spectral power over developing dementia in Parkinson’s disease

V.V. Cozac, M. Chaturvedi, U. Gschwandtner, F. Hatz, A. Meyer, K. Nowak, R. Sturzenegger, P. Fuhr (Basel, Switzerland)
Predictive validity of statistical models of Parkinson’s disease progression

A. Mendes, A. Gonçalves, N. Vila-Chã, M. Calejo, I. Moreira, J. Fernandes, J. Damásio, A. Bastos-Lima, S. Cavaco (Porto, Portugal)
Predictors of clinically meaningful change in PDQ-39 in Parkinson’s disease

T. Simuni, S. Wu, Y. He, C. Marras, T. Davis, E. Nelson, F. Cubillos, P. Schmidt, On behalf of the NPF QII Investigators (Chicago, IL, USA)
Predictors of dementia in Parkinson’s disease: A population-based cohort study

A. Keener, K. Paul, A. Folle, J. Bronstein, B. Ritz (Los Angeles, CA, USA)
Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia

J. Jankovic, S. Marc, A. Aubrey (Houston, TX, USA)
Predictors of quality of life in Huntington’s disease. A longitudinal observational study

A. Brás, F. Júlio, M. Sousa, F. Blanco, C. Januário (Coimbra, Portugal)
Predictors of recurrent falls in people with Parkinson’s disease and development of a predictive tool

L.R.S. Almeida, G.T. Valenca, N.N. Negreiros, E.B. Pinto, J. Oliveira-Filho (Salvador, Brazil)
Predictors of transfer to community hospital or nursing home after discharge of inpatients with Parkinson’s disease: A Japanese single center retrospective study

K. Ikeda, K. Takahashi, T. Furuya, A. Miyake, T. Mitsufuji, A. Tanaka, Y. Ito, T. Sasaki, Y. Nakazato, N. Araki, T. Yamamoto (Saitama-ken, Japan)
Predominant motor neuron involvement in autosomal recessive SYNE1 ataxia

W. Nachbauer, A. Schossig, C. Fauth, W. Poewe, S. Boesch (Innsbruck, Austria)
Preliminary findings of MR imaging of the entire spinal cord in Friedreich’s ataxia

K. Reetz, S. Romanzetti, I. Dogan, M.L. Macel, D. Timmann, I.A. Giordano, T. Klockgether, J.B. Schulz (Aachen, Germany)
Preliminary results for a study on quality of life in Huntington’s disease patients and their caregivers in Peru

A. Vishnevetsky, M.A. Inca-Martinez, M. Illanes-Manrique, M. Cornejo-Olivas (Lima, Peru)
Preliminary results of a cross-linguistic comparison on dysarthria in Parkinson’s disease

J. Sadat, R. Cardoso, H. Santos, J. Carvalho, I. Guimarães, F. Viallet, J.J. Ferreira, S. Pinto (Aix-en-Provence, France)
Premotor phase of PD in two GBA mutation carriers

N. Kresojevic, M. Jankovic, I. Petrovic, V. Dobricic, N. Dragasevic, M. Svetel, L. Brajkovic, V. Kostic (Belgrade, Serbia)
Premotor symptoms as prognostic indicators of Parkinson’s disease: A nationwide population-based and case-control study

M.H. Chang (Taichung, Taiwan)
Prescribed gait tests versus continuous monitoring of gait in people with Parkinson’s disease

C. Curtze, J. McNames, M. El-Gohary, J.G. Nutt, M. Mancini, P. Carlson-Kuhta, F.B. Horak (Portland, OR, USA)
Presenting symptoms and cognitive profile in Lewy body dementia: A series of cases

B. Minafra, G.M.D. Toscano, M. Picascia, R. Zangaglia, N.G. Pozzi, M. Terzaghi, R. Manni, E. Sinforiani, C. Pacchetti (Pavia, Italy)
Presynaptic dopamine depletion predicts late complications and time of progression to advanced disease in patients with early Parkinson’s disease

R. Djaldetti, L. Greenbaum, M. Lorberboym (Petah Tiqva, Israel)
Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with multiple system atrophy

M. Renaud, D. Robert, A. Lagier, H. Somma, S. Soulayrol, D. Korchia, F. Fluchère, S. Grimaldi, T. Witjas, J.P. Azulay, A. Eusebio (Marseille, France)
Prevalence and incidence of PSP and CBS: A new prospective study in the UK

J.B. Rowe, I.T. Coyle-Gilchrist (Cambridge, United Kingdom)
Prevalence and risk factors for orthostatic hypotension in early PD

C. McDonald, R.A. Lawson, G.W. Duncan, T.K. Khoo, D.J. Brooks, R.A. Barker, A.J. Yarnall, D.J. Burn (Newcastle upon Tyne, United Kingdom)
Prevalence and risk factors of orthostatic hypotension in Thai Parkinson’s disease patients

S. Klanbut, S. Wongwiwatthananukit, C. Suthisisang, R. Bhidayasiri, S. Phattanarudee (Bangkok, Thailand)
Prevalence of depression and dementia in Parkinson’s disease

A. Kalendarev, F. Yunusov, G. Rakhimbaeva (Tashkent, Uzbekistan)
Prevalence of depression in Parkinson’s disease patients

A.M. Weldehana (Addis Ababa, Ethiopia)
Prevalence of hemifacial spasm in Northern Cyprus

S. Usar Incirli, F. Selcuk, C.M. Akbostanci (Nicosia, Cyprus)
Prevalence of impulse control disorders among adult Filipino patients with idiopathic Parkinson’s disease seen at a tertiary center in Manila

J.K.P. de Guzman, A.D. Yap, C.L. Go (Manila, Philippines)
Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism

G. Calandra-Buonaura, L. Sambati, I. Gessaroli, A. Turrini, R. Terlizzi, G. Giannini, P. Guaraldi, P. Cortelli (Bologna, Italy)
Prevalence of Parkinson’s disease and myotonic dystrophy in the nomadic population: Mongolian study

T. Sosorburam, B. Samdan, J. Amar (Ulan-Bator, Mongolia)
Prevalence of Parkinson’s disease in the region of Coquimbo, Chile

M. Contreras, P. Pizarro, U. Hernandez, C. Gomez, J. Gajardo (La Serena, Chile)
Prevalence of Parkinson’s disease in Ukraine

Y.O. Trufanov, N.K. Svyrydova, A.I. Galusha, G.M. Chupryna, O.V. Popov, M.V. Nechkalyuk (Kyiv, Ukraine)
Prevalence of restless legs syndrome in an atypical Parkinson’s disease population

J.R.P. Zuzuárregui, K. Werbaneth, S. Lee, C. Branson, M.H. Saint-Hilaire, A.D. Hohler (Boston, MA, USA)
Priapism and hypersexuality associated with rotigotine in an elderly Parkinsonian patient: A case report

A. Cannas, M. Meloni, M.M. Mascia, P. Solla, G. Orofino, R. Farris, D. Ciaccio, E. Binaghi, F. Marrosu (Nuoro, Italy)
Primary progressive aphasia and frontotemporal dementia in an Irish-American family due to a novel progranulin mutation

D.A. Olszewska, A. McCarthy, E.D. Huey, I. Delon, G. Pope, A. Blanco-Campal, T. Lynch (Dublin, Ireland)
Primidone-related connective tissue disorders in essential tremor

C.S.B. Germano, M. Spitz, L.F.R. Vasconcellos (Rio de Janeiro, Brazil)
Probable REM sleep behaviour disorder and detrusor overactivity in primary cervical dystonia- A case report

S.L. Bhadran, M.G.J. Jacob, S. Kripal (Thrissur, India)
Prodromal criteria of spinocerebellar type 2: Lessons for physiopathology, natural history and therapeutical trials

L. Velázquez-Pérez, R. Rodríguez-Labrada, N. Canales-Ochoa, J. Fernandez-Ruiz, J. Medrano-Montero, Y. Vazquez-Mojena, G. Auburger, U. Ziemann (Holguín, Cuba)
Prodromal Parkinson’s disease in Argentinean patients with Gaucher disease type 1: Preliminary report

E.M. Gatto, J.L. Etcheverry, N. Basack, L. Aversa, N. Fernández Escobar, B. Soberón, A. Sanguinetti, M. Cesarini, G. Drelichman, E.M. Gatto (Buenos Aires, Argentina)
Profile of depressive symptoms in Parkinson’s disease patients and a population-based elderly cohort

K. Hückelheim, E.J. Vollstedt, S. Tunc, J. Hampf, J. Graf, V. Tadic, C. Klein, M. Kasten (Lübeck, Germany)
Profile of urgent care visits in movement disorders

J.T. Lazarus, V.D. Sharma, L. Scorr, S. Factor (Atlanta, GA, USA)
Prognostic factors of motor symptoms in Parkinson’s disease using neuromelanin imaging and the relationship with (123)I-FP-CIT-SPECT

A. Okuzumi, T. Hatano, K. Kamagata, M. Hori, S. Aoki, N. Hattori (Tokyo, Japan)
Program evaluation empowerment of people with Huntington’s disease (HD) and their families: Using goal attainment scaling (GAS)

D. Alburquerque, N. Rojas, S. Tapia, P. Reyes, C. Silva, P. Chana-Cuevas (Santiago, Chile)
Progress in the development of small molecules based on the coumarin core as multifunctional neuroprotective agents

M.J. Matos, D. Viña, F. Rodríguez-Enríquez, S. Vilar, L. Santana, E. Uriarte (Santiago de Compostela, Spain)
Progression of microglial activation and neuroinflammatory responses in a transgenic mouse model of multiple system atrophy

V. Refolo, S. Venezia, G.K. Wenning, M. Romero-Ramos, N. Stefanova (Innsbruck, Austria)
Progression of motor subtypes in Huntington’s disease: A six-year follow-up

M. Jacobs, E.P. 't Hart, R.A.C. Roos (Leiden, Netherlands)
Progressive ataxia and palatal tremor: A case report

G. Fabiani, J. Yared, H.A.G. Teive (Campina Grande do Sul, Brazil)
Progressive atrophy of parahippocampal gyrus correlates with Hoehn & Yahr stages of Parkinson’s disease: A voxel based morphometric study

P.K. Pal, R.M. Naduthota, L. George, K. Jhunjhunwala, J. Saini, R.D. Bharath, A. Lenka, R. Yadav (Bangalore, India)
Progressive encephalomyelitis with rigidity and myoclonus (PERM) in an intellectually disabled patient initially misdiagnosed as neuroleptic malignant syndrome (NMS)

Z. Xu, K. Prasad, T. Yeo (Singapore, Singapore)
Progressive supranuclear palsy as a manifestation of the second stage of CADASIL syndrome

B. Muinjonov, E. Giyazitdinova, G. Rakhimbaeva (Tashkent, Uzbekistan)
Prolonged cerebellar syndrome after Legionnaire’s disease

B.R. Barton (Chicago, IL, USA)
Promoting optimal physiotherapy practice worldwide: Role of the Association of Physiotherapists in Parkinson’s disease Europe (APPDE)

M. Graziano, D. Jones, B. Ramaswamy, F. Lindop (Esch-sur-Alzette, Luxembourg)
Pronounced beta oscillations are a characteristic of the cortico-basal ganglia loop of subacute and chronic animal models of Parkinson´s disease

C. van Riesen, J.K. Haumesser, J. Kühn, A. Kühn, M.H. Beck (Berlin, Germany)
Propranolol therapy for tardive dyskinesia: A retrospective examination

S.A. Factor, K.A. Armstrong, J.M. Hatcher-Martin (Atlanta, GA, USA)
Proprioceptive training as a means to enhance sensorimotor function in Parkinson’s disease

N. Elangovan, P. Tuite, J. Konczak (Minneapolis, MN, USA)
PROSPECT: A UK-based longitudinal observational study of PSP, CBD, MSA and atypical parkinsonism syndromes

J. Woodside, R. Lamb, V. Chelban, D. Burn, A. Church, A. Gerhard, M. Hu, N. Leigh, J. Rowe, H. Houlden (London, United Kingdom)
Prospective evaluation of pallidal deep brain stimulation in Huntington’s disease

S. Zittel, V. Tadic, C. Moll, A. Fellbrich, N. Brüggemann, D. Rasche, T. Bäumer, V. Tronnier, A. Münchau (Luebeck, Germany)
Protective effects of ATP13A2 in Parkinson’s disease models

S. Martin, S. van Veen, J. Zielich, T. Holemans, C. van den Haute, V. Beakelandt, P. Agostinis, P. Vangheluwe (Leuven, Belgium)
Protein levels of SV2A and VGLUT1 in brain tissue from patients with Parkinson’s disease, dementia with Lewy bodies and Alzheimer’s disease

S. Frykman, M. Oosterhof, M.S. Ahmed, D. Howlet, T. Hortobagyi, P. Francis, D. Årsland (Huddinge, Sweden)
Pseudodystonic upper limb secondary to thalamic lesions: Usefulness of ultrasound-guided botulinum toxin treatment

C. Costa, P. Pita Lobo (Amadora, Portugal)
Pshychoeducational interventions for demented patients with parkinsonism and their families

P.N.S. Almeida, A.C.P. Koutsandréou, A.C.M. Neri (Salvador, Brazil)
PSP and HIV: Causality or coincidence?

L.A. Crespo Araico, P. Agüero Rabes, E. Viedma Guiard, P. Martinez Ulloa, C. Estévez Fraga, A. Alonso Cánovas, I. Corral Corral, L. Cabañes Martinez, E. Navas Elorza, J.C. Martinez Castrillo, I. Avilés Olmos (Madrid, Spain)
Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study

M. Smit, A. Kuiper, V. Han, V.C.R. Jiawan, G. Douma, B. van Harten, J.M.T.H. Oen, M.E. Pouwels, H.J.G. Dieks, A.L. Bartels, M.A.J. Tijssen (Groningen, Netherlands)
Psychiatric disorders and personality traits in patients with functional dystonia

A. Tomic, M. Svetel, I. Petrovic, N. Dragasevic Miskovic, D. Pesic, M. Mitkovic, A. Potrebic, N. Kresojevic, V.S. Kostic (Belgrade, Serbia)
Psychiatric manifestations in the initial motor stage of Parkinson’s disease

I. Stankovic, E. Stefanova, A. Tomic, M. Jecmenica Lukic, V. Markovic, N. Kresojevic, I. Petrovic, M. Svetel, V.S. Kostic (Belgrade, Serbia)
Psychiatric profile in functional (psychogenic) jerky movement disorders

Y.E.M. Dreissen, T.J. van Trier, J.M. Dijk, D.C. Cath, M.A.J. Tijssen (Amsterdam, Netherlands)
Psychogenic gait disorders in children – Report of 2 cases

S. Lorenzl, M. Kranz (Hausham, Germany)
Psychogenic movement disorder in cerebellar atrophy

P. Sommer, D. Földy, O. Khalifa, E. Fertl (Vienna, Austria)
Psychogenic non-epileptic seizures among patients with temporal lobe and other epilepsies: Phenomenology and EEG correlates

B.D. Wissel, A.K. Dwivedi, T.E. Gaston, F.J. Rodriguez-Porcel, D. Al Jaafari, J.L. Hopp, A. Krumholz, Y. Wang, S.M.A. van der Salm, D.M. Andrade, F. Borlot, B.D. Moseley, J.L. Cavitt, S. Williams, J. Stone, W.C. LaFrance Jr, J.P. Szaflarski, A.J. Espay (Cincinnati, OH, USA)
Psychosis in Huntington’s disease

J. Perez-Perez, S. Martinez-Horta, M. Carceller, J. Pagonabarraga, A. Horta, R. Fernandez-Bobabilla, J. Kulisevsky (Barcelona, Spain)
Pulmonary dysfunction in Parkinson’s disease: A feature of early disease?

G. Baille, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)